ASTH

Astrana Health, Inc. ( ASTH ) Q3 2026 Earnings Call November 5, 2026 5:30 PM EST Company Participants Brandon Sim - President & CEO Chan Basho - CFO, COO & Corporate Secretary Conference Call Participants Jack Slevin - Jefferies LLC, Research Division Hua Ha - Robert W. Baird & Co. Incorporated, Research Division Andrew Mok - Barclays Bank PLC, Research Division Ryan Langston - TD Cowen, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division David Larsen - BTIG, LLC, Research Division Ryan Daniels - William Blair & Company L.L.C.

Astrana Health NASDAQ: ASTH reported record third-quarter revenue and adjusted EBITDA as growth in Medicare Advantage membership and full-risk contracts helped offset declines in Medicaid and exchange enrollment.

Company to Host Conference Call on Thursday, November 5, 2026, at 2:30 p.m. PT/5:30 p.m.

NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the "Company") (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the "Company") (NASDAQ: ASTH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

ALHAMBRA, Calif., Oct. 9, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2026, after the close of the stock market on Thursday, November 5, 2026.

Astrana Health, Inc. (ASTH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the "Company") (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.